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Summary
Deletions encompassing the 5′ termini of the paired type
IV collagen genes COL4A5 and COL4A6 on chromo-
some Xq22 give rise to Alport syndrome (AS) and as-
sociated diffuse leiomyomatosis (DL), a syndrome of dis-
seminated smooth-muscle tumors involving the esoph-
agus, large airways, and female reproductive tract. In
this study, we report isolation and characterization of
two deletion junctions. The first, in a patient described
elsewhere, arose by a nonhomologous recombination
event fusing a LINE-1 (L1) repetitive element in intron
1 of COL4A5 to intron 2 of COL4A6, resulting in a
13.4-kb deletion. The second, in a previously unde-
scribed family, arose by unequal homologous recombi-
nation between the same L1 and a colinear L1 element
in intron 2 of COL4A6, resulting in a 140-kb deletion.
L1 elements have contributed to the emergence of this
locus as a site of frequent recombinations by diverse
mechanisms. These give rise to AS-DL by disruption of
type IV collagen and perhaps other as yet unidentified
genes, evidenced by deletions as small as 13.4 kb.
Introduction
Alport syndrome (AS) or “hereditary nephritis” (MIM
104200, 301050) is a predominantly X-linked disorder
that is marked by hematuria and progressive renal failure
in affected males and is often accompanied by hearing
loss and ocular abnormalities (Alport 1927; Gregory and
Atkin 1993). Female carriers generally exhibit a milder
phenotype, although exceptions are well known (Has-
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stedt et al. 1986). A small subset of affected individuals
manifest an associated syndrome called “diffuse leiom-
yomatosis” (DL), characterized by disseminated smooth-
muscle tumors of the esophagus, upper airways, and
female genitalia (Cochat et al. 1988; Garcia-Torres and
Orozco 1993). Leiomyomas are equally penetrant in
males and females and can present sporadically (Heidet
et al. 1998).
Most cases of X-linked AS are attributable to muta-
tions in the COL4A5 gene, which is arranged head-to-
head on chromosome Xq22 with the closely related
COL4A6 gene. Together with the gene pairs COL4A1-
COL4A2 and COL4A3-COL4A4, which are arranged
head-to-head on chromosomes 13 and 2, respectively,
COL4A5 and COL4A6 encode the a1-a6 chains of type
IV collagen, which form triple-helical monomers of var-
iable and tissue-specific composition and function as a
lattice network in basement membranes (reviewed in
Hudson et al. 1993; Timpl and Brown 1996). It is likely
that the genomic arrangement of the type IV collagen
genes arose by a series of duplications from an ancestral
gene (Zhou et al. 1994). To date, 160 pathogenic mu-
tations in COL4A5 have been described, including de-
letions, insertions, rearrangements, and single base-pair
substitutions (Tryggvason 1996). Patients with AS-DL
characteristically have large deletions in the COL4A5-
COL4A6 locus, which encompasses the 5′-most exons
of COL4A5 and COL4A6 and their intergenic region
(Zhou et al. 1993). In cases examined to date, there is
loss of immunoreactivity to the a5 and a6 chains in
basement membranes (Heidet et al. 1997a).
The basis for smooth-muscle tumors in AS-DL is un-
known. We and others have postulated that DL arises
not strictly as a result of loss of the a5 and a6 chains
but as a result of disruption of an as yet unidentified
gene(s). Two major lines of evidence point to this like-
lihood. First, cases of AS arising from mutations in
COL4A5 generally are associated with loss of immu-
noreactivity for the a3-a6 chains in kidney and other
organs (Kleppel et al. 1989; Nakanishi et al. 1994; Peis-
sel et al. 1995), implying that loss of the a5 and a6
chains—although perhaps necessary for DL—is not suf-
ficient. Second, deletions in the COL4A5-COL4A6 lo-
Segal et al.: Recombination Events in AS-DL 63
Figure 1 Pedigree of the YP family. The proband (P) YP128 is
indicated by an arrow (R). The blackened symbols refer to affected
family members, as outlined in Patients and Methods.
Figure 2 Southern analysis of the DON deletion. Hybridization
with use of probes D1 and D2 demonstrated an abnormal 7.5-kb SacI
fragment in genomic DNA from the DON patient, in contrast to the
expected 4.3- and 10.2-kb fragments (see fig. 3 for map).
cus extending beyond the third exon of COL4A6 are
associated with AS but not with DL (Heidet et al. 1995,
1997b). This finding is consistent with a scheme in which
disruption of gene(s) or genetic regulatory element(s) in
the locus gives rise to smooth-muscle tumors by gain of
function, in a manner abrogated by more extensive
deletions.
Long-range mapping studies indicate breakpoint var-
iability in AS-DL–associated deletions (Heidet et al.
1995, 1997b). Correlations between the extent of de-
letions with expression of the DL phenotype have been
used to map a “critical” region for additional genes to
a 90-kb region encompassing exon 3 of COL4A6 (Hei-
det et al. 1997b). In an alternative approach, we pos-
tulated that the smallest known deletions giving rise to
DL might directly disrupt or cause dysregulation of can-
didate gene(s) for DL. As such, we report refined map-
ping and molecular cloning of the deletion junction in
a patient with a deletion described elsewhere (Renieri et
al. 1994). In addition, we report a deletion junction in
a previously undescribed family with AS-DL, and we use
this to characterize further the basis for diverse recom-
bination events generating deletions in this locus. Our
findings provide greater molecular detail of the locus and
highlight factors that may predispose uniquely to re-
combination events giving rise to AS-DL.
Patients and Methods
Patients
Patient DON has been described elsewhere (Renieri
et al. 1994). In brief, he is an adopted 30-year-old man,
diagnosed with AS at 6 years of age, who progressed to
end-stage renal disease by age 16 years and subsequently
underwent renal transplantation. Esophageal leiomy-
omas were diagnosed during his early twenties. The pa-
tient has bilateral high-tone hearing loss and bilateral
cataracts with right lenticonus.
Patient YP128 is a 29-year-old man, from the pedigree
shown in figure 1. Hematuria was first detected at age
11 years. Renal biopsy specimens obtained at age 16
years showed splitting and fragmentation of the glom-
erular basement membrane at the electron microscopic
level, which is characteristic of AS. Progression to end-
stage renal disease occurred by age 25 years. Esophageal
leiomyomas were resected partially at age 17 years. Bi-
lateral cataracts and sensorineural hearing loss were doc-
umented during the patient’s twenties. The patient’s sis-
ter, YP142, progressed to end-stage renal disease by age
30 years. She underwent partial resection of esophageal
leiomyomas and resection and reconstructive surgery for
vulvar leiomyomas during her teens. During her twen-
ties, she underwent anal sphincterotomy and excision of
the internal anal sphincter, for severe constipation sec-
ondary to hypertrophy of these structures. She has bi-
lateral cataracts and asthma. The mother of these pa-
tients is age 60 years. She underwent esophagomyotomy
at age 40 years. She has microscopic hematuria and a
serum creatinine level of 1.3 mg/dl. She has no clinically
evident hearing loss or ocular abnormalities.
Southern Analysis
Epstein-Barr virus–transformed cell lines were pre-
pared from patient blood samples and genomic DNA
isolated by use of standard techniques (Dracopoli et al.
1997). After overnight digestion, DNA samples (5 mg)
were separated on 0.8% agarose gels and transferred to
Magnagraph nylon membranes (Micron Separations).
Probes were prepared by 32P-dCTP random labeling,
with the following templates. D2 from intron 1 of
COL4A5 is a 710-bp PCR product obtained by use of
primers 5′ CAAGAATGTTTCTGACTTGGC 3′ and 5′
TCTACATTACAACTAACCTTATC 3′. D1, Y1, and Y2
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Table 1
PCR Primer Sequences
Template Forward Primer (5′–3′) Reverse Primer (5′–3′)
DON:
Undigested DF1 TCAATCAGACCTTGATTTGAGTGCAGC DR1 ATCGCCAAGTCAATCCTAAGCCA
DF2 AGGGGGCAAAGTGTGAAG DR2 ACAAATCTACAACTATCTGATC
YP128:
EcoRI-digested, circularized YF1 CAACATACCCATGAGGTCCCTTTGG YR1 TGTAGCAAGAATGTTTCTGACTTGGC
SacI-digested, circularized YF1 TGTAGCAAGAATGTTTCTGACTTGGC YR2 CGTAGTCAAGTCTATACTGACTAAGG
Undigested YF2 GGCAAGCACAGAAGCAGAAAGGC YR1 TGTAGCAAGAATGTTTCTGACTTGGC
Wild-type:
SacI-digested, linearized YF2 GGCAAGCACAGAAGCAGAAAGGC YR3 ACATCAACAAATCCAAATGGACATCC
from intron 2 of COL4A6 are 330-bp Sau3AI, 1.1-kb
HindIII, and 260-bp StuI-SacI fragments, respectively.
The a6 cDNA fragment JZ-3-FR5, covering one of two
alternative first exons to exon 4 of COL4A6, has been
described elsewhere (Zhou et al. 1993). Hybridization
in 50% formamide-containing buffer and subsequent
washings were carried out by use of standard techniques
(Ausubel et al. 1987). Bands were visualized by means
of autoradiography.
PCR Amplification
Cosmid clone U176D11 (Renieri et al. 1994), encom-
passing the 5′ ends of the COL4A5 and COL4A6 genes,
was partially sequenced for the purpose of designing
primers for PCR amplification across patient deletion
junctions. For patient DON, a first reaction was per-
formed on genomic DNA by use of primers DF1 and
DR1 (table 1 and fig. 3), followed by a nested reaction
using primers DF2 and DR2. Patient YP128 has a
COL4A5 breakpoint in intron 1 (see Results). The
COL4A6 breakpoint region was isolated by inverse PCR
(Triglia et al. 1988). Total genomic DNA was digested
with EcoRI, circularized with T4 ligase, and amplified
with outward-facing primers YF1 and YR1 (table 1 and
fig. 4), yielding a 2.8-kb product, which was cloned and
sequenced. Flanking sequence was also isolated by use
of inverse PCR. To extend in the COL4A6 direction,
genomic DNA from patient YP128 was digested with
SacI, circularized, and amplified with outward-facing
primers YF1 and YR2, the latter from the COL4A6
breakpoint region. To extend in the COL4A5 direction,
genomic DNA from an unaffected individual was di-
gested with SacI, circularized, and amplified by use of
YF2 and YR3, yielding a 4.5-kb product, which was
cloned as an EcoRI-SacI restriction fragment. Amplifi-
cation across the YP128 deletion junction was per-
formed with primers YF2 and YR1.
Immunofluorescence
Immunofluorescence was performed as described else-
where (Peissel et al. 1995). In brief, skin biopsy materials
obtained from YP128 and a control individual were
maintained in OCT at80C. Sections of 2–4-mm thick-
ness were cut at 20C and denatured by use of urea-
glycine (pH 3) for 1 h at 4C. Staining for the C-terminal
NC1 domains of the a1, a5, and a6 chains of type IV
collagen was performed with primary antibodies, as de-
scribed elsewhere (Peissel et al. 1995), and with appro-
priate fluorophore-conjugated secondary antibodies.
Staining was visualized, after mounting, by means of
epifluorescent illumination.
Results
Characterization of Deletion Junctions
Southern analysis of genomic DNA from patient DON
has been used broadly to define a 15–19-kb deletion that
encompasses the first exon of COL4A5 (E1), two alter-
native first exons of COL4A6 (E1a and E1b), and the
second exon of COL4A6 (E2) (Renieri et al. 1994). We
used genomic probes D1 and D2, from the deletion-
flanking regions, to identify an abnormal 7.5-kb SacI
fragment and, thus, narrowed the deletion to 13.4 kb
(fig. 2). This is one of the smallest known deletions as-
sociated with AS-DL (see Heidet et al. 1995). PCR am-
plification across the deletion junction revealed fusion
of a 5′-truncated L1 repetitive element in intron 1 of
COL4A5 to a nonrepetitive sequence in intron 2 of
COL4A6, with interposition of a 70-bp poly-A/T stretch
(fig. 3). The L1 element has been described elsewhere
(Ueki et al. 1998). It contains nucleotides 3617–5979 of
an arbitrary full-length L1 consensus sequence (Genbank
accession number U93574) and therein lacks the two
open reading frames associated with functional elements
(Sassaman et al. 1997). The COL4A5 breakpoint is in
its poly-A tail, whereas the COL4A6 breakpoint is in a
poly-A/T stretch 16 bp in length, which is arranged tail-
to-tail on the same strand.
In preliminary Southern analysis of genomic DNA
from patients Y128 and Y142, using probe JZ-3-FR5,
we confirmed a characteristic deletion involving exons
E1 of COL4A5 and E1a, E1b, and E2 of COL4A6, with
Figure 3 Deletion junction in the DON patient. The 5′-most exons of COL4A5 (unblackened bar) and COL4A6 (blackened bars), L1
repeat, SacI (S) restriction sites, probes D1 and D2, and PCR primers (arrowheads) are indicated on the map. Sequence from the deletion
junction revealed fusion of a poly-A/T stretch on the COL4A6 side to the poly-A tail-derived region of the L1 repeat, with an insertion of a
70-bp stretch of poly-A/T.
Figure 4 Southern analysis of the YP128 deletion. Probes D2 and Y1 revealed an abnormal 5.2-kb SacI fragment, and probe D2 an
abnormal 3.5-kb EcoRI fragment, in patient YP128 and his sister, YP142, compared with the control pattern (see fig. 5).
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Figure 5 Deletion junction in the YP128 patient. A map containing the intergenic region (see fig. 3) and the COL4A6 breakpoint region
indicates the second L1 repeat; probes Y1, Y2, and D2; PCR primers (arrowheads; see Patients and Methods and table 1); and SacI (S) and
EcoRI (E) restriction sites. The L1 repeats are compared schematically against a full-length consensus element, with regions of homology filled
similarly. The mutant allele arises by unequal homologous recombination between the L1 elements.
Figure 6 Recombination interval in the YP128 patient. Comparison among the wild-typeCOL4A5 andCOL4A6L1-containingbreakpoint
regions and the YP128 deletion junction is shown. Mismatches are shaded. With a single exception, suggesting a patient polymorphism (indicated
by an asterisk [*]), mismatches segregate around the underlined interval 4518–4559. Numbering is in reverse order, corresponding to an arbitrary
L1 consensus sequence (see text).
sparing of exon 3 (not shown). Using probe D2, we
identified abnormal 5.2-kb SacI and 3.5-kb EcoRI frag-
ments (fig. 4). A probe from the COL4A6 terminus of
cosmid U230F3 (Renieri et al. 1994) did not hybridize
against genomic DNA from patient YP128 (not shown),
which placed the lower limit of the deletion at 40 kb.
The deletion junction was isolated by PCR amplification
(see Patients and Methods). Comparison with wild-type
genomic DNA provided evidence for an unequal ho-
mologous recombination event involving the L1 repeat
in intron 1 of COL4A5 and a second rearranged L1 in
intron 2 of COL4A6, the latter containing nucleotides
3621–4424 and 4405–4908 of the consensus element,
in a head-to-head arrangement (fig. 5). The abnormal
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Figure 7 Immunostaining of type IV collagen chains. Epidermal basement membrane (arrowhead) in a skin biopsy specimen from patient
YP128 did not stain with specific antibodies against the a6(IV) collagen chain (a), in contrast to a normal control (b). The same specimen
stained positively for the a1(IV) collagen chain in epidermal and other skin basement membranes (c). Original magnification #75.
5.2-kb SacI fragment was verified by use of probe Y1
from the COL4A6 breakpoint region (fig. 5). Using se-
quence comparison, we localized the recombination in-
terval to nucleotides 4518–4559 (fig. 6). Southern anal-
ysis by use of probe Y2 from the deleted region provided
no evidence of a reciprocal duplication in genomic DNA
from maternally derived, transformed lymphoblasts (not
shown), such as might be expected from a recombination
event involving two X chromosomes in a female with
somatic mosaicism.
Immunophenotypic Characterization of Patient YP128
Immunostaining of a skin biopsy specimen from pa-
tient YP128 was performed to investigate the possibility
that the a5 and a6 chains of type IV collagen are ex-
pressed as disease-associated N-terminally truncated
forms. Against this hypothesis, we observed the absence
of the normal pattern of distribution of the a6 chain in
the epidermal basement membrane, as compared with a
normal skin sample (fig. 7; see Peissel et al. 1995). Im-
munoreactivity to the a5 chain was also lost (not
shown), whereas that to a1 was preserved.
Discussion
Insights into the pathogenesis of smooth-muscle tu-
mors in AS-DL are likely to have broader implications
for the control of cell growth. As a first step toward
uncovering its basis, we undertook detailed molecular
analysis of deletions associated with AS-DL and initiated
investigation of expressed sequences likely to be affected
by these mutations. Our major finding is that deletions
in this region arise by diverse mechanisms from resident
L1 repeats. This class of repetitive elements, which has
evolved from an archetypal transposable element, rep-
resents an estimated 10%–15% of the human genome
(Kazazian and Moran 1998) and has been implicated in
several deletion syndromes (Henthorn et al. 1990;
Drechsler and Royer-Pokora 1996). It remains to be seen
whether the involvement of L1 repeats in AS-DL will
prove disproportionate to their representation in the lo-
cus or will extend beyond the selection bias inherent in
this initial characterization of deletions.
The DON deletion, with its interposition of a 70-bp
stretch of poly-A/T, is unique in its kind. Although the
mechanism of the deletion is unclear, inspection of the
deletion junction provides some insights. The insertion
is flanked on both sides by A/T-rich regions (fig. 3). If
these arose as overhangs after double-stranded breaks,
then repair might have been accomplished by oligonu-
cleotide capture, wherein a preformed oligonucleo-
tide—likely a poly-A tail—served in a bridging inter-
mediate structure, with the subsequent generation of a
junction by means of filling in and nick ligation. In prin-
ciple, a repair mechanism using “filler DNA” (Roth et
al. 1989) could have occurred in the context of an intra-
or interchromosomal event in the maternal germ line.
Precedent for an intrachromosomal event is provided by
an earlier description of a male with AS-DL, who
showed somatic mosaicism for a pathogenic deletion,
also involving the L1 repeat in intron 1 of COL4A5
(Ueki et al. 1998). Interestingly, breakpoints in this de-
letion arose at topoisomerase I and II consensus-binding
sites, which led to their direct implication in the event.
In the DON deletion junction no such sites are evident,
although clearly this does not exclude the involvement
of these enzymes.
To our knowledge, the deletion in the YP128 family
represents only the second reported deletion arising from
an unequal homologous recombination between neigh-
boring L1 elements. In the first, the recombination event
gave rise to a 7.5-kb deletion in the phosphorylase kinase
b–subunit gene, which included a single coding exon,
and caused glycogen storage disease in a homozygous
male born to consanguineous parents (Burwinkel and
Kilimann 1998). That these events are detected rarely,
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in spite of the abundance of L1 elements in the human
genome, has been pointed out by others, who have also
posed possible explanations, among them: (1) that these
repeats may occur preferentially in gene-poor regions,
such that recombination events are clinically silent; (2)
that frequent and extensive mutations over evolution
have limited the homology among elements; and (3) that,
in spite of their abundance, L1 elements occur at infre-
quent intervals, rendering recombinations involving co-
linear elements unlikely (Burwinkel and Kilimann 1998).
It will be interesting to ascertain whether exceptions to
these general postulates apply in the COL4A5-COL4A6
locus, favoring this as a hot spot for deletions. Further,
it is tempting to speculate that these or other as yet
uncharacterized repetitive elements may have played a
role in the original duplications giving rise to the type
IV collagen gene family (Zhou et al. 1994). Insight into
this possibility will require broader knowledge of the
COL4A1-COL4A2 and COL4A3-COL4A4 loci.
The characterization of these deletions does not allow
us to distinguish among the possible mechanisms of tu-
morigenesis in AS-DL (see Introduction). In the YP128
patient, we found loss of a5 and a6 immunoreactivity,
which is consistent with findings in other affected in-
dividuals (Heidet et al. 1997a, 1998) and provides ev-
idence against the role(s) of N-terminally truncated type
IV collagen chains in this syndrome. Loss of the a5 and
a6 chains per se is not likely sufficient to cause the dis-
ease, as this is also the prevalent finding in AS attrib-
utable to mutations in the COL4A5 gene alone (Peissel
et al. 1995). Of course, loss of type IV collagen chains
could be a contributing factor, as there is evidence of a
disordered substratum in esophageal leiomyomas by
morphological and immunocytochemical criteria (Hei-
det et al. 1997a). It is possible that the subunit com-
position of type IV collagen in affected individuals favors
incremental derangements in AS-DL as compared to AS
(e.g., if homotrimers of the a6 chain occur and are pre-
served selectively in AS). We remain intrigued by the
possibility that additional genes are contained within the
COL4A5-COL4A6 locus, which confers gain of func-
tion, causing smooth-muscle tumors, and that these ad-
ditional genes are rendered functionally null by deletions
extending beyond exon 3 of COL4A6. It is noteworthy
that these genes would be subject to disruption in de-
letions as small as 13.4 kb.
To summarize, we have characterized the molecular
features of two pathogenic deletions in AS-DL. Com-
parison of these deletions provides evidence of their hav-
ing arisen by two different mechanisms, involving non-
homologous recombination in the DON patient and an
unequal homologous recombination in the YP128 fam-
ily. The participation of L1 repeats emphasizes their im-
portance—perhaps as vestiges of a primordial duplica-
tion event—and raises the possibility that the emergence
of this locus as a hot spot for recombination may have
followed from their strategic localization.
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